Molecular Diagnosis of COVID-19

Roshan Niloofa, Suranjith L Seneviratne, Akila Cooray, Nilanthi Senanayake, Ishan De Zoysa

Abstract


The SARS-CoV-2 coronavirus causes COVID-19. Nucleic acid amplification tests (NAAT), could be used to detect the presence of SARS-CoV-2 viral RNA in clinical samples. Several real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) assays are being used by many laboratories for confirming COVID-19. We have outlined the characteristics of the available SARS-Cov-2 rRT-PCR assays and discussed its clinical utility.


Keywords


SARS-Cov-2; Covid-19; RT-PCR, molecular diagnosis

Full Text:

PDF

References


Seneviratne SL, Abeysuriya V, de Mel S, De Zoysa I, Niloofa R. Favipiravir in Covid-19. International Journal of Progressive Sciences and Technologies 2020; 19: 143 - 145

Day M. Covid-19: four fifths of cases are asymptomatic, china figures indicate. BMJ 2020;369:m1375. Published 2 April 2020. doi: 10.1136/bmj.m1375

Lv DF, Ying QM, Weng YS, Shen CB, Chu JG, Kong JP, et al. Dynamic change of target genes by RT-PCR testing of SARS-CoV-2 during the course of a Coronavirus Disease 2019 patient. Clinica Chimica Acta. Published online ahead of print: 27 March 2020. Doi: 10.1016/j.cca.2020.03.032.

Corman VM, Landt O, Kaise M, Molenkamp R, Meijer A, Chu Dk, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045. doi:10.2807/1560-7917.ES.2020.25.3.2000045

Chu DK, Pan Y, Cheng SM, Hui KP, Krishnan P, Liu Y, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 2020; 66 (4): 549-555. Doi: 10.1093/clinchem/hvaa029

Chan JFW, Yip CCP, To KKW, Thang THC, Wong SCY, Leung KH, et al. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated and with clinical specimens. J Clin Microbiol. 2020. Published online ahead of print: 04 March 2020. doi: 10.1128/JCM.00310-20.

Yip CCY, Ho CC, Chan JFW, To KKW, Chan HSY, Wong SCY, et al. Development of a novel, genome subtraction-derived, SARS-CoV-2-specific COVID-19-nsp2-real time RT-PCR assay and its evaluation using clinical specimens. Int J Mol Sci. 2020; 21: 2574. Doi: 10.3390/ijms21072574

Yu F, Yan L, Wang N, Yang S, Wang L, Tang Y, et al. Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients. Clin Infect Dis. Published online ahead of print: 28 March 2020. Doi: 10.1093/cid/ciaa345

Liu R, Han H, Liu F, Lv Z, Wu K, Liu Y, et al. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clinica Chimica Acta. Published online ahead of print: 2020 Mar 7. doi: 10.1016/j.cca.2020.03.009

Long C, Xu H, Shen Q, Zhang X, Fan B. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? Radiology. 2020. Published online ahead of print: 25 March 2020. doi: 10.1016/j.ejrad.2020.108961

Lamb LE, Bartolone SN, Ward E, Chancellor MB. Rapid Detection of Novel Coronavirus (COVID19) by Reverse Transcription-Loop-Mediated Isothermal Amplification. The Lancet. Published online ahead of print: 2020 February 14. doi:10.2139/ssrn.3539654

Pfefferle S, Rvenja R, Nors D, Lutghetmann M. Evaluation of a quantitative of a RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system. Euro Survell. 2020;25(9):pii=2000152. Doi: 10.2807/1560-7917.ES.2020.25.9.2000152


Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Roshan Niloofa, Suranjith L Seneviratne, Akila Cooray, Nilanthi Senanayake, Ishan De Zoysa

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.